IPA - ImmunoPrecise Antibodies Ltd.
IEX Last Trade
0.5285
0.003 0.568%
Share volume: 431,535
Last Updated: Fri 10 Jan 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.23%
PREVIOUS CLOSE
CHG
CHG%
$0.53
-0.02
-0.03%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-1.42%
1 Month
21.16%
3 Months
-9.64%
6 Months
-46.84%
1 Year
-65.72%
2 Year
-90.02%
Key data
Stock price
$0.53
DAY RANGE
$0.51 - $0.58
52 WEEK RANGE
$0.38 - $2.60
52 WEEK CHANGE
-$65.72
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Jennifer L. Bath
Region: US
Website: ipatherapeutics.com
Employees: 80
IPO year: 2008
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: ipatherapeutics.com
Employees: 80
IPO year: 2008
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
ImmunoPrecise Antibodies Ltd. engages in antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products.
Recent news